The global NDDS Cancer Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Liquid Embolic Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of NDDS Cancer Therapy include Advanced Medical Isotope Corporation, Boston Scientific Corporation, CeloNova Biosciences, Inc., Cook Medical, Inc., Cospheric LLC, Eckert & Ziegler BEBIG, Kobo Products, Inc., Medtronic plc and Merit Medical Systems, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for NDDS Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NDDS Cancer Therapy. This report contains market size and forecasts of NDDS Cancer Therapy in global, including the following market information:
Global NDDS Cancer Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the NDDS Cancer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NDDS Cancer Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global NDDS Cancer Therapy Market Segment Percentages, by Type, 2022 (%)
Liquid Embolic
Embolization Particle
Nanoparticles
Global NDDS Cancer Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global NDDS Cancer Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global NDDS Cancer Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global NDDS Cancer Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NDDS Cancer Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies NDDS Cancer Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Advanced Medical Isotope Corporation
Boston Scientific Corporation
CeloNova Biosciences, Inc.
Cook Medical, Inc.
Cospheric LLC
Eckert & Ziegler BEBIG
Kobo Products, Inc.
Medtronic plc
Merit Medical Systems, Inc.
Mo-Sci Corporation
Nanobiotix
Pfizer, Inc.
Polysciences, Inc.
Sirtex Medical, Inc.
Terumo Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of NDDS Cancer Therapy, market overview.
Chapter 2: Global NDDS Cancer Therapy market size in revenue.
Chapter 3: Detailed analysis of NDDS Cancer Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of NDDS Cancer Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 NDDS Cancer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global NDDS Cancer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global NDDS Cancer Therapy Overall Market Size
2.1 Global NDDS Cancer Therapy Market Size: 2022 VS 2029
2.2 Global NDDS Cancer Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top NDDS Cancer Therapy Players in Global Market
3.2 Top Global NDDS Cancer Therapy Companies Ranked by Revenue
3.3 Global NDDS Cancer Therapy Revenue by Companies
3.4 Top 3 and Top 5 NDDS Cancer Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies NDDS Cancer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 NDDS Cancer Therapy Players in Global Market
3.6.1 List of Global Tier 1 NDDS Cancer Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 NDDS Cancer Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global NDDS Cancer Therapy Market Size Markets, 2022 & 2029
4.1.2 Liquid Embolic
4.1.3 Embolization Particle
4.1.4 Nanoparticles
4.2 By Type - Global NDDS Cancer Therapy Revenue & Forecasts
4.2.1 By Type - Global NDDS Cancer Therapy Revenue, 2018-2023
4.2.2 By Type - Global NDDS Cancer Therapy Revenue, 2024-2029
4.2.3 By Type - Global NDDS Cancer Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global NDDS Cancer Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global NDDS Cancer Therapy Revenue & Forecasts
5.2.1 By Application - Global NDDS Cancer Therapy Revenue, 2018-2023
5.2.2 By Application - Global NDDS Cancer Therapy Revenue, 2024-2029
5.2.3 By Application - Global NDDS Cancer Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global NDDS Cancer Therapy Market Size, 2022 & 2029
6.2 By Region - Global NDDS Cancer Therapy Revenue & Forecasts
6.2.1 By Region - Global NDDS Cancer Therapy Revenue, 2018-2023
6.2.2 By Region - Global NDDS Cancer Therapy Revenue, 2024-2029
6.2.3 By Region - Global NDDS Cancer Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America NDDS Cancer Therapy Revenue, 2018-2029
6.3.2 US NDDS Cancer Therapy Market Size, 2018-2029
6.3.3 Canada NDDS Cancer Therapy Market Size, 2018-2029
6.3.4 Mexico NDDS Cancer Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe NDDS Cancer Therapy Revenue, 2018-2029
6.4.2 Germany NDDS Cancer Therapy Market Size, 2018-2029
6.4.3 France NDDS Cancer Therapy Market Size, 2018-2029
6.4.4 U.K. NDDS Cancer Therapy Market Size, 2018-2029
6.4.5 Italy NDDS Cancer Therapy Market Size, 2018-2029
6.4.6 Russia NDDS Cancer Therapy Market Size, 2018-2029
6.4.7 Nordic Countries NDDS Cancer Therapy Market Size, 2018-2029
6.4.8 Benelux NDDS Cancer Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia NDDS Cancer Therapy Revenue, 2018-2029
6.5.2 China NDDS Cancer Therapy Market Size, 2018-2029
6.5.3 Japan NDDS Cancer Therapy Market Size, 2018-2029
6.5.4 South Korea NDDS Cancer Therapy Market Size, 2018-2029
6.5.5 Southeast Asia NDDS Cancer Therapy Market Size, 2018-2029
6.5.6 India NDDS Cancer Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America NDDS Cancer Therapy Revenue, 2018-2029
6.6.2 Brazil NDDS Cancer Therapy Market Size, 2018-2029
6.6.3 Argentina NDDS Cancer Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa NDDS Cancer Therapy Revenue, 2018-2029
6.7.2 Turkey NDDS Cancer Therapy Market Size, 2018-2029
6.7.3 Israel NDDS Cancer Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia NDDS Cancer Therapy Market Size, 2018-2029
6.7.5 UAE NDDS Cancer Therapy Market Size, 2018-2029
7 NDDS Cancer Therapy Companies Profiles
7.1 Advanced Medical Isotope Corporation
7.1.1 Advanced Medical Isotope Corporation Company Summary
7.1.2 Advanced Medical Isotope Corporation Business Overview
7.1.3 Advanced Medical Isotope Corporation NDDS Cancer Therapy Major Product Offerings
7.1.4 Advanced Medical Isotope Corporation NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.1.5 Advanced Medical Isotope Corporation Key News & Latest Developments
7.2 Boston Scientific Corporation
7.2.1 Boston Scientific Corporation Company Summary
7.2.2 Boston Scientific Corporation Business Overview
7.2.3 Boston Scientific Corporation NDDS Cancer Therapy Major Product Offerings
7.2.4 Boston Scientific Corporation NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.2.5 Boston Scientific Corporation Key News & Latest Developments
7.3 CeloNova Biosciences, Inc.
7.3.1 CeloNova Biosciences, Inc. Company Summary
7.3.2 CeloNova Biosciences, Inc. Business Overview
7.3.3 CeloNova Biosciences, Inc. NDDS Cancer Therapy Major Product Offerings
7.3.4 CeloNova Biosciences, Inc. NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.3.5 CeloNova Biosciences, Inc. Key News & Latest Developments
7.4 Cook Medical, Inc.
7.4.1 Cook Medical, Inc. Company Summary
7.4.2 Cook Medical, Inc. Business Overview
7.4.3 Cook Medical, Inc. NDDS Cancer Therapy Major Product Offerings
7.4.4 Cook Medical, Inc. NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.4.5 Cook Medical, Inc. Key News & Latest Developments
7.5 Cospheric LLC
7.5.1 Cospheric LLC Company Summary
7.5.2 Cospheric LLC Business Overview
7.5.3 Cospheric LLC NDDS Cancer Therapy Major Product Offerings
7.5.4 Cospheric LLC NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.5.5 Cospheric LLC Key News & Latest Developments
7.6 Eckert & Ziegler BEBIG
7.6.1 Eckert & Ziegler BEBIG Company Summary
7.6.2 Eckert & Ziegler BEBIG Business Overview
7.6.3 Eckert & Ziegler BEBIG NDDS Cancer Therapy Major Product Offerings
7.6.4 Eckert & Ziegler BEBIG NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.6.5 Eckert & Ziegler BEBIG Key News & Latest Developments
7.7 Kobo Products, Inc.
7.7.1 Kobo Products, Inc. Company Summary
7.7.2 Kobo Products, Inc. Business Overview
7.7.3 Kobo Products, Inc. NDDS Cancer Therapy Major Product Offerings
7.7.4 Kobo Products, Inc. NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.7.5 Kobo Products, Inc. Key News & Latest Developments
7.8 Medtronic plc
7.8.1 Medtronic plc Company Summary
7.8.2 Medtronic plc Business Overview
7.8.3 Medtronic plc NDDS Cancer Therapy Major Product Offerings
7.8.4 Medtronic plc NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.8.5 Medtronic plc Key News & Latest Developments
7.9 Merit Medical Systems, Inc.
7.9.1 Merit Medical Systems, Inc. Company Summary
7.9.2 Merit Medical Systems, Inc. Business Overview
7.9.3 Merit Medical Systems, Inc. NDDS Cancer Therapy Major Product Offerings
7.9.4 Merit Medical Systems, Inc. NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.9.5 Merit Medical Systems, Inc. Key News & Latest Developments
7.10 Mo-Sci Corporation
7.10.1 Mo-Sci Corporation Company Summary
7.10.2 Mo-Sci Corporation Business Overview
7.10.3 Mo-Sci Corporation NDDS Cancer Therapy Major Product Offerings
7.10.4 Mo-Sci Corporation NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.10.5 Mo-Sci Corporation Key News & Latest Developments
7.11 Nanobiotix
7.11.1 Nanobiotix Company Summary
7.11.2 Nanobiotix Business Overview
7.11.3 Nanobiotix NDDS Cancer Therapy Major Product Offerings
7.11.4 Nanobiotix NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.11.5 Nanobiotix Key News & Latest Developments
7.12 Pfizer, Inc.
7.12.1 Pfizer, Inc. Company Summary
7.12.2 Pfizer, Inc. Business Overview
7.12.3 Pfizer, Inc. NDDS Cancer Therapy Major Product Offerings
7.12.4 Pfizer, Inc. NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.12.5 Pfizer, Inc. Key News & Latest Developments
7.13 Polysciences, Inc.
7.13.1 Polysciences, Inc. Company Summary
7.13.2 Polysciences, Inc. Business Overview
7.13.3 Polysciences, Inc. NDDS Cancer Therapy Major Product Offerings
7.13.4 Polysciences, Inc. NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.13.5 Polysciences, Inc. Key News & Latest Developments
7.14 Sirtex Medical, Inc.
7.14.1 Sirtex Medical, Inc. Company Summary
7.14.2 Sirtex Medical, Inc. Business Overview
7.14.3 Sirtex Medical, Inc. NDDS Cancer Therapy Major Product Offerings
7.14.4 Sirtex Medical, Inc. NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.14.5 Sirtex Medical, Inc. Key News & Latest Developments
7.15 Terumo Corporation
7.15.1 Terumo Corporation Company Summary
7.15.2 Terumo Corporation Business Overview
7.15.3 Terumo Corporation NDDS Cancer Therapy Major Product Offerings
7.15.4 Terumo Corporation NDDS Cancer Therapy Revenue in Global Market (2018-2023)
7.15.5 Terumo Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report